Medica Sur SAB de CV
BMV:MEDICAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Medica Sur SAB de CV
BMV:MEDICAB
|
MX |
|
A
|
Aifeex Nexus Acquisition Corp
NASDAQ:AIFE
|
US |
|
E
|
Encavis AG
XBER:ECV
|
DE |
|
Aristocrat Leisure Ltd
ASX:ALL
|
AU |
|
F
|
FedEx Corp
SWB:FDX
|
US |
|
ITD Cementation India Ltd
NSE:ITDCEM
|
IN |
|
Amte Power PLC
LSE:AMTE
|
UK |
|
E
|
E Star Commercial Management Co Ltd
HKEX:6668
|
CN |
Wall Street
Price Targets
MEDICAB Price Targets Summary
Medica Sur SAB de CV
According to Wall Street analysts, the average 1-year price target for
MEDICAB
is 93.84 MXN
with a low forecast of 92.92 MXN and a high forecast of 96.6 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is MEDICAB's stock price target?
Price Target
93.84
MXN
According to Wall Street analysts, the average 1-year price target for
MEDICAB
is 93.84 MXN
with a low forecast of 92.92 MXN and a high forecast of 96.6 MXN.
What is Medica Sur SAB de CV's Revenue forecast?
Projected CAGR
-9%
For the last 13 years the
compound annual growth rate for
Medica Sur SAB de CV's revenue is
7%.
The projected
CAGR
for the next 4 years is
-9%.
What is Medica Sur SAB de CV's Operating Income forecast?
Projected CAGR
-3%
For the last 13 years the
compound annual growth rate for
Medica Sur SAB de CV's operating income is
4%.
The projected
CAGR
for the next 4 years is
-3%.
What is Medica Sur SAB de CV's Net Income forecast?
Projected CAGR
-15%
For the last 13 years the
compound annual growth rate for
Medica Sur SAB de CV's net income is
6%.
The projected
CAGR
for the next 4 years is
-15%.
